Transgenic mice expressing a human poliovirus receptor: A new model for poliomyelitis

Ruibao Ren, Frank Costantini, Edward J. Gorgacz, James J. Lee, Vincent R. Racaniello

Research output: Contribution to journalArticlepeer-review

300 Scopus citations


A human poliovirus receptor (PVR) gene was used to generate transgenic mice that express PVR transcripts and poliovirus binding sites in a wide range of tissues: Intracerebral inoculation of PVR transgenic mice with poliovirus type 1, Mahoney strain, resulted in viral replication in the brain and spinal cord and development of paralytic poliomyelitis. P1/Mahoney did not replicate or cause paralysis in nontransgenic mice. PVR transgenic mice failed to develop clinical disease when inoculated intracerebrally with the live attenuated Sabin type 1 vaccine strain. These results demonstrate that the PVR is the major determinant of poliovirus host range in mice. Transgenic mice expressing human PVR should be useful for studying poliovirus neurovirulence, attenuation, and tissue tropism, and for development and testing of poliovirus vaccine strains.

Original languageEnglish (US)
Pages (from-to)353-362
Number of pages10
Issue number2
StatePublished - Oct 19 1990

ASJC Scopus subject areas

  • General Biochemistry, Genetics and Molecular Biology


Dive into the research topics of 'Transgenic mice expressing a human poliovirus receptor: A new model for poliomyelitis'. Together they form a unique fingerprint.

Cite this